Table 5.
Comparison of Clinical and Laboratory Parameters on Day 1,3, and 5.
| Variable | Day 1 |
P Value | Day 3 |
P value | Day 5 |
P Value | |||
|---|---|---|---|---|---|---|---|---|---|
| Group A N = 104 |
Group B N = 54 |
Group A N = 104 |
Group B N = 54 |
Group A N = 104 |
Group B N = 54 |
||||
| MAP (mm of Hg) (median) (IQR) |
82 (80–86) | 82(80–84) | 0.505b | 82 (80–84) | 82 (80–84) | 0.829b | 80 (80–82) | 81(80–84) | 0.667b |
| MELDNa score (mean ± SD) | 22.19 ± 6.26 | 23.55 ± 7.35 | 0.229a | 20.73 ± 6.05 | 21.92 ± 7.70 | 0.901a | 20.36 ± 6.14 | 21.85 ± 7.93 | 0.197a |
| CTP score (median) (IQR) | 10(9–11) | 10(8–12) | 0.508b | 9 (8–11) | 9 (8–11) | 0.836b | 9(8–10) | 9(8–11) | 0.893b |
| SOFA score (mean ± SD) | 3.62 ± 2.02 | 3.64 ± 1.93 | 0.964a | 3.61 ± 2.07 | 3.67 ± 2.29 | 0.682a | 3.77 ± 2.57 | 3.75 ± 2.53 | 0.960a |
| Serum creatinine(mg/dl) (median) (IQR) | 0.93 (0.63–1.24) | 0.95 (0.66–1.38) | 0.343b | 0.83 (0.62–1.18) | 0.83 (0.60–1.27) | 0.852b | 0.78 (0.59–1.10) | 0.74 (0.57–1.26) | 0.861b |
| INR (median) (IQR) | 1.60 (1.41–1.93) | 1.61 (1.36–2.14) | 0.384b | 1.58 (1.30–2.0) | 1.65 (1.37–2.0) | 0.557b | 1.60 (1.29–1.86) | 1.60 (1.37–2.02) | 0.247b |
| Serum bilirubin(mg/dl) (median) (IQR) | 2.57 (1.19–6.90) | 2.67 (1.55–8.81) | 0.169b | 2.47 (1.17–6.69) | 2.88 (1.44–9.08) | 0.216b | 2.30 (1.10–7.25) | 3.15 (1.33–8.00) | 0.929b |
| Serum albumin(mg/dl) (median) (IQR) | 2.60 (2.40–2.90) | 2.50 (2.20–2.90) | 0.169b | 2.60 (2.4–3.0) | 2.60 (2.30–3.10) | 0.899b | 2.80 (2.50–3.10) | 2.80 (2.40–3.30) | 0.663b |
CTP = Child-Turcotte-Pugh; INR = international normalized ratio; IQR = Inter quartile range; MAP = Mean arterial pressure; MELDNa = Model for end stage liver disease sodium; SD = Standard deviation; SOFA = Sequential organ failure assessment score.
Independent t test.
Mann–Whitney U test.